NASDAQ:BEAM

Beam Therapeutics Stock Dividends

Healthcare > Biotechnology

Buy BEAM

*Your capital is at risk

$35.53

+1.39 (+4.07%)

At Close: Jun 22, 2026

BEAM Dividends Insights

BEAM used to pay dividends quarterly. Last paid amount was $0.225 at Mar 03, 2014. As of today, dividend yield (TTM) is 0%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score
Start 7-Day Free Trial

AI Analysis of BEAM

AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.

AI Analysis of BEAM

AI-Powered Market Insights

New!

Dividend Analysis

Key Stats

Dividend Yield (TTM)	0%
Frequency	Quarterly
1Y Growth	0%
Payout Ratio	0
Amount Per Share	$0.225
Beam Therapeutics Inc. has not yet announced its next dividend date. Last payment date was: Mar 03, 2014.

BEAM Dividend Payout History

To ensure a understanding of BEAM's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.

#	Declaration Date	Ex-Date	Pay Date	Amount	Yield
1	Jan 22, 2014	Feb 04, 2014	Mar 03, 2014	$0.225	0%
2	Sep 19, 2013	Nov 04, 2013	Dec 02, 2013	$0.225	0%
3	Jul 31, 2013	Aug 12, 2013	Sep 03, 2013	$0.225	0%
4	Apr 24, 2013	May 06, 2013	Jun 03, 2013	$0.225	0%
5	Jan 28, 2013	Feb 04, 2013	Mar 01, 2013	$0.225	0%
6	Oct 04, 2012	Nov 05, 2012	Dec 03, 2012	$0.210	0%
7	Jul 24, 2012	Aug 06, 2012	Sep 04, 2012	$0.210	0%
8	Apr 26, 2012	May 07, 2012	Jun 01, 2012	$0.210	0%
9	Jan 30, 2012	Feb 06, 2012	Mar 01, 2012	$0.210	0%
10	Nov 07, 2011	Nov 07, 2011	Dec 01, 2011	$0.190	0%

Requires Login

Dividend Sustainability

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Overall, the near-term dividend outlook remains unpromising.

DSS - Sustainability score

Low (50.00%)

DSGP - Growth potential

No dividend growth expected in the near future

BEAM Stock Competitors

Symbol	Company Name	Market Cap	Amount Per Share	Dividend Yield (TTM)	Payout Ratio (TTM)
BEAM	Beam Therapeutics Inc.	3.512B	$0.225	0%	-

FAQ

What factors can affect the amount of BEAM's dividend payments?

The amount of BEAM's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in BEAM sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from BEAM stock be automatically reinvested?

If BEAM offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy BEAM stock.

How often does BEAM pay dividend?

Beam Therapeutics Inc. (BEAM) used to pay dividends quarterly. The most recent payout was on Mar 03, 2014.

How much does BEAM pays per share?

The last recorder (Feb 04, 2014) dividend per share was $0.225.

What is BEAM dividend growth rate?

Over the last year, Beam Therapeutics Inc. has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 0%. Furthermore, examining the past 5 years, Beam Therapeutics Inc. has maintained an average Dividends Per Share Growth Rate of 0%.

ABOUT BEAM THERAPEUTICS INC.

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
IDYA $28.98	18.12%	Jun 12
DHI $146.71	6.29%	Jun 10
PHM $118.49	6.02%	Jun 10
EAT $140.46	17.09%	Jun 05
E ETD $20.67	3.19%	Jun 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by